Minocycline inhibits apoptotic cell death in a murine model of partial flap loss

Journal of Reconstructive Microsurgery

Volumn 26, Issue 8, 2010, Pages 523-528

  Dumont, Ewald A W J ^a   Lutgens, Suzanne P M ^b   Reutelingsperger, Christopher P M ^c   Bos, Gerard M J ^b   Hofstra, Lenoard ^b  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

annexin A5; apoptosis; breast reconstruction; DIEP flap; Free flap; minocycline

Indexed keywords

LIPOCORTIN 5; MINOCYCLINE; PHOSPHATIDYLSERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL CULTURE; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DEEP INFERIOR EPIGASTRIC PERFORATOR FLAP; DRUG EFFECT; DRUG INHIBITION; GRAFT FAILURE; ISCHEMIA; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION;

ANIMALS; APOPTOSIS; BIOPSY, NEEDLE; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EPIGASTRIC ARTERIES; FEMALE; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MAMMAPLASTY; MICE; MINOCYCLINE; RANDOM ALLOCATION; RECTUS ABDOMINIS; REFERENCE VALUES; REGIONAL BLOOD FLOW; SURGICAL FLAPS;

EID: 77956972821     PISSN: 0743684X     EISSN: 10988947     Source Type: Journal    
DOI: 10.1055/s-0030-1262952     Document Type: Article

References (16)

1. Erdmann D, Sundin B M., Moquin K J., Young H, Georgiade G S. Delay in unipedicled TRAM flap reconstruction of the breast: a review of 76 consecutive cases. Plast Reconstr Surg 2002 110 762-767
2. Hartrampf C R. Jr. The transverse abdominal island flap for breast reconstruction. A 7-year experience. Clin Plast Surg 1988 15 703-716
3. Paige K T., Bostwick J III, Bried J T., Jones G. A comparison of morbidity from bilateral, unipedicled and unilateral, unipedicled TRAM flap breast reconstructions. Plast Reconstr Surg 1998 101 1819-1827
4. Lineaweaver W C., Lei M P., Mustain W, Oswald T M., Cui D, Zhang F. Vascular endothelium growth factor, surgical delay, and skin flap survival. Ann Surg 2004 239 866-873 discussion 873-875
5. Dumont E A., Reutelingsperger C P., Smits J F. et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 2001 7 1352-1355
6. Hofstra L, Dumont E A., Thimister P W. et al. In vivo detection of apoptosis in an intracardiac tumor. JAMA 2001 285 1841-1842
7. Dumont E A., Hofstra L, van Heerde W L. et al. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 2000 102 1564-1568
8. Hofstra L, Liem I H., Dumont E A. et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000 356 209-212
9. Yrjänheikki J, Tikka T, Keinänen R, Goldsteins G, Chan P H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 1999 96 13496-13500
10. Sutton T A., Kelly K J., Mang H E., Plotkin Z, Sandoval R M., Dagher P C. Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury. Am J Physiol Renal Physiol 2005 288 F91-F97
11. Klein M B., Chan P H., Chang J. Protective effects of superoxide dismutase against ischemia-reperfusion injury: development and application of a transgenic animal model. Plast Reconstr Surg 2003 111 251-255 discussion 256-257
12. Hallock G G., Rice D C. Comparison of TRAM and DIEP flap physiology in a rat model. Plast Reconstr Surg 2004 114 1179-1184
13. Gieseler A, Schultze A T., Kupsch K et al. Inhibitory modulation of the mitochondrial permeability transition by minocycline. Biochem Pharmacol 2009 77 888-896
14. Orsucci D, Calsolaro V, Mancuso M, Siciliano G. Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol Disord Drug Targets 2009 8 222-231
15. Scarabelli T M., Stephanou A, Pasini E et al. Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol 2004 43 865-874
16. Sapadin A N., Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006 54 258-265